Apogee Therapeutics(US:APGE) ZACKS·2025-10-30 14:56Core Viewpoint - Apogee Therapeutics Inc. (APGE) has seen a significant stock price increase of 41.4% over the past four weeks, closing at $55.7, with analysts suggesting a potential upside of 69.3% based on a mean price target of $94.3 [1][11]. Price Targets and Analyst Estimates - The mean estimate for APGE comprises 10 short-term price targets with a standard deviation of $16.3, indicating variability among analysts. The lowest estimate suggests a 7.7% increase to $60.00, while the highest estimate predicts a surge of 108.3% to $116.00 [2][9]. - A tight clustering of price targets, represented by a low standard deviation, indicates a high degree of agreement among analysts regarding the stock's price movement direction [9]. Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising earnings per share (EPS) estimates higher for APGE, which is a positive indicator for potential stock upside. This correlation between earnings estimate revisions and stock price movements is supported by empirical research [4][11]. - Over the past 30 days, one estimate for APGE has increased, leading to a 0.9% rise in the Zacks Consensus Estimate, with no negative revisions noted [12]. Zacks Rank and Investment Potential - APGE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, which further supports its potential upside [13]. - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a useful guide for the direction of price movement [14].